Authors:
Wu, MH
Liebowitz, DN
Smith, SL
Williams, SF
Dolan, ME
Citation: Mh. Wu et al., Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation, GENE THER, 8(5), 2001, pp. 384-390
Authors:
Laport, GG
Fleming, GF
Waggoner, S
Zimmerman, TM
Grinblatt, DL
Williams, SF
Citation: Gg. Laport et al., A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer, BONE MAR TR, 27(7), 2001, pp. 677-681
Authors:
Wu, MH
Smith, SL
Danet, GH
Lin, AM
Williams, SF
Liebowitz, DN
Dolan, ME
Citation: Mh. Wu et al., Optimization of culture conditions to enhance transfection of human CD34(+) cells by electroporation, BONE MAR TR, 27(11), 2001, pp. 1201-1209
Authors:
Laport, GG
Valone, FH
Zimmerman, TM
Grinblatt, DL
Van Vlasselaer, P
Still, BJ
Williams, SF
Citation: Gg. Laport et al., Transplantation with low-density autologous PBSC prepared with BDS60 for women with stage II, III and IV breast cancer, CYTOTHERAPY, 2(3), 2000, pp. 179-185
Authors:
Zimmerman, TM
Lee, WJ
Bender, JG
Schilling, M
Smith, SL
Van Epps, DE
Williams, SF
Citation: Tm. Zimmerman et al., Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue, BONE MAR TR, 26(5), 2000, pp. 505-510
Authors:
Brockstein, BE
Smiley, C
Al-Sadir, J
Williams, SF
Citation: Be. Brockstein et al., Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors, BONE MAR TR, 25(8), 2000, pp. 885-894
Authors:
Shammo, JM
Smith, SL
Bennett, MV
Lee, HW
Ostrander, A
Ross, AA
Williams, SF
Citation: Jm. Shammo et al., Use of a tumor-cell enrichment column for the enhanced detection of minimal residual disease in the BM or apheresis peripheral blood transplant products of breast-cancer patients, CYTOTHERAPY, 1(5), 1999, pp. 367-376
Authors:
Hollingsworth, KL
Zimmerman, TM
Karrison, T
Oliver, A
Williams, SF
Citation: Kl. Hollingsworth et al., The CD34+cell concentration in peripheral blood predicts CD34+cell yield in the leukapheresis product, CYTOTHERAPY, 1(2), 1999, pp. 141-146
Authors:
Zimmerman, TM
Michelson, GC
Mick, R
Grinblatt, DL
Williams, SF
Citation: Tm. Zimmerman et al., Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma, J CLIN APH, 14(1), 1999, pp. 31-34
Authors:
Sobecks, RM
Le Beau, MM
Anastasi, J
Williams, SF
Citation: Rm. Sobecks et al., Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation, BONE MAR TR, 23(11), 1999, pp. 1161-1165
Authors:
Rowlings, PA
Williams, SF
Antman, KH
Fields, KK
Fay, JW
Reed, E
Pelz, CJ
Klein, JP
Sobocinski, KA
Kennedy, MJ
Freytes, CO
McCarthy, PL
Herzig, RH
Stadtmauer, EA
Lazarus, HM
Pecora, AL
Bitran, JD
Wolff, SN
Gale, RP
Armitage, JO
Vaughan, WP
Spitzer, G
Horowitz, MM
Citation: Pa. Rowlings et al., Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer, J AM MED A, 282(14), 1999, pp. 1335-1343
Authors:
Shpall, EJ
Wheeler, CA
Turner, SA
Yanovich, S
Brown, RA
Pecora, AL
Shea, TC
Mangan, KF
Williams, SF
LeMaistre, CF
Long, GD
Jones, R
Davis, MW
Murphy-Filkins, R
Parker, WRL
Glaspy, JA
Citation: Ej. Shpall et al., A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients, BLOOD, 93(8), 1999, pp. 2491-2501
Citation: Tm. Zimmerman et Sf. Williams, Clinical applications of ex vivo cultured CD34(+) cells and myeloid progenitors, CYTOK CELL, 4(4), 1998, pp. 257-264